Patents by Inventor Stefanie Lindemann

Stefanie Lindemann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • POWDEROUS COMPOSITION (III)
    Publication number: 20240108044
    Abstract: The present invention relates to a powderous composition comprising at least one carotenoid and/or one carotenoid derivative, which can be produced easily and which can be used in many fields of application.
    Type: Application
    Filed: February 8, 2022
    Publication date: April 4, 2024
    Inventors: Stefanie KIRCHEN, Thomas LINDEMANN, Christian SCHAEFER, Roland SCHEX, Thomas ZWICK
  • POWDEROUS COMPOSITION(II)
    Publication number: 20240090550
    Abstract: The present invention relates a powderous composition comprising at least one polyunsaturated fatty acid, which can be produced easily and which can be used in many fields of application.
    Type: Application
    Filed: February 8, 2022
    Publication date: March 21, 2024
    Inventors: Stefanie KIRCHEN, Thomas LINDEMANN
  • POWDEROUS COMPOSITION (I)
    Publication number: 20240090558
    Abstract: The present invention relates a powderous composition comprising at least one fat-soluble vitamin, which can be produced easily and which can be used in many fields of application.
    Type: Application
    Filed: February 8, 2022
    Publication date: March 21, 2024
    Inventors: Stefanie KIRCHEN, Thomas LINDEMANN
  • Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
    Patent number: 9579330
    Abstract: The invention relates to a method of hormonal female controlled “on demand” contraception, in which a pharmaceutical preparation comprising a COX inhibitor and levonorgestrel is taken on demand prior to expected sexual intercourse. Further subjects of the invention relate to pharmaceutical compositions and application regimes for “on demand” contraception.
    Type: Grant
    Filed: November 19, 2013
    Date of Patent: February 28, 2017
    Assignee: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Bernhard Lindenthal, Katrin Waellnitz, Peter Serno, Stefanie Lindemann, Ulrike Fuhrmann
  • USE AND APPLICATION REGIMEN OF A PHARMACEUTICAL COMPOSITION CONTAINING LEVONORGESTREL AND A COX INHIBITOR FOR ON-DEMAND CONTRACEPTION
    Publication number: 20160000805
    Abstract: The invention relates to a method of hormonal female controlled “on demand” contraception, in which a pharmaceutical preparation comprising a COX inhibitor and levonorgestrel is taken on demand prior to expected sexual intercourse. Further subjects of the invention relate to pharmaceutical compositions and application regimes for “on demand” contraception.
    Type: Application
    Filed: November 19, 2013
    Publication date: January 7, 2016
    Inventors: Bernhard LINDENTHAL, Katrin WAELLNITZ, Peter SERNO, Stefanie LINDEMANN, Ulrike FUHRMANN
  • MEDICATION FOR ORAL ADMINISTRATION, COMPRISING AT LEAST ONE ESTROGEN AND/OR AT LEAST ONE GESTAGEN AND AT LEAST ONE PROBIOTIC BACTERIAL STRAIN
    Publication number: 20120189599
    Abstract: The present invention relates to a medicament for oral administration containing at least one estrogen and/or one gestagen and at least one probiotic bacterial strain, such as for example lactobacillus species. The medicament according to the invention is used either for oral contraception or for hormone therapy (HT), during which it can simultaneously serve for the stabilization of the vaginal environment and hence the prevention of infectious diseases, such as for example vaginal mycosis, bacterial vaginosis and/or bladder inflammation (bacterial cystitis) or the prevention of urogenital symptoms, e.g. dyspareunia and dysuria. The present invention further relates to pharmaceutical combination preparations which contain dosage units containing an aforesaid medicament and further dosage units containing exclusively a probiotic bacterial strain.
    Type: Application
    Filed: May 14, 2010
    Publication date: July 26, 2012
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Stefanie Lindemann, Sascha General